Known targets — ChEMBL curated mechanism
ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2026240 | 0.98 | TKT (0.54) | TKTHSP90AA1 | |
| Iodide SCHEMBL1779438 | 0.96 | TKT (0.52) | TKTHSP90AA1 | |
| Hydrochloric Acid SCHEMBL7760396 | 0.96 | TKT (0.52) | TKTHSP90AA1 | |
| Sulfuric Acid SCHEMBL17102694 | 0.89 | TKT (0.47) | TKTHSP90AA1 | |
| Bromide SCHEMBL8941023 | 0.87 | TKT (0.54) | TKTHSP90AA1 | |
| Albitiazolium SCHEMBL2017697 | 0.82 | TKT (0.50) | TKTHSP90AA1 | |
| Bromide SCHEMBL5627875 | 0.80 | TKT (0.52) | TKTHSP90AA1 | |
| Bromide SCHEMBL3844686 | 0.80 | TKT (0.50) | TKTHSP90AA1 | |
| Bromide SCHEMBL3853203 | 0.80 | TKT (0.48) | TKTHSP90AA1 | |
| Bromide SCHEMBL10841344 | 0.79 | TKT (0.45) | TKTHSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 573 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119701994-A | Ferromanganese-based catalyst for preparing methyl methacrylate and preparation and application thereof | 中国科学院大连化学物理研究所 | 2025-03-28 | — | — | CN | claimed |
| CN-116789577-A | Preparation method of mesotrione compounds | 北京颖泰嘉和生物科技股份有限公司 | 2023-09-22 | — | — | CN | claimed |
| CN-115116751-B | Aluminum electrolytic capacitor electrolyte, preparation method thereof and aluminum electrolytic capacitor | 深圳市新中元电子有限公司 | 2023-03-21 | — | — | CN | claimed |
| EP-3906235-B1 | METHOD FOR PREPARING SULFONAMIDES DRUGS | ASCENTAGE PHARMA SUZHOU CO LTD (CN) | 2023-03-15 | — | — | EP | claimed |
| CN-115116751-A | Aluminum electrolytic capacitor electrolyte, preparation method thereof and aluminum electrolytic capacitor | 深圳市新中元电子有限公司 | 2022-09-27 | — | — | CN | claimed |
| US-11414400-B2 | Method for preparing sulfonamides drugs | ASCENTAGE PHARMA (SUZHOU) CO., LTD. (CN) | 2022-08-16 | — | — | US | claimed |
| CN-114031564-A | 13, 14-picene quinoxaline and 13, 14-picene diazole derivatives and preparation method thereof | 华东师范大学 | 2022-02-11 | — | — | CN | claimed |
| US-20210221788-A1 | METHOD FOR PREPARING SULFONAMIDES DRUGS | ASCENTAGE PHARMA GROUP CORP LIMITED (CN) | 2021-07-22 | — | — | US | claimed |
| CN-111410650-B | Process for the preparation of sulfonamides | 苏州亚盛药业有限公司 | 2020-12-08 | — | — | CN | claimed |
| CN-111533655-A | Preparation method of long-carbon-chain keto dicarboxylic ester | 广东工业大学 | 2020-08-14 | — | — | CN | claimed |
| US-5514505-A | SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE | XEROX CORPORATION (US) | 1996-05-07 | — | — | US | claimed |
| EP-0402151-B1 | New 2, 5-diaryl tetrahydrofurans and analogs thereof as paf antagonists | MERCK & CO INC (US) | 1996-02-07 | — | — | EP | claimed |
| EP-0615854-A1 | Recording sheets containing cationic sulphur compounds | XEROX CORPORATION (US) | 1994-09-21 | — | — | EP | claimed |
| EP-0330172-B1 | Improved process for trans-6-[2-(substituted-pyrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis | WARNER LAMBERT CO (US) | 1994-08-10 | — | — | EP | claimed |
| US-5314747-A | Recording sheets containing cationic sulfur compounds | XEROX CORPORATION (US) | 1994-05-24 | — | — | US | claimed |
| US-5216174-A | Process for trans-6-[12-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis | WARNER-LAMBERT CO. (US) | 1993-06-01 | — | — | US | claimed |
| EP-0448552-A1 | IMPROVED PROCESS FOR $i(TRANS)-6- 2-(SUBSTITUTED-PYRROL-1-YL)ALKYL]PYRAN-2-ONE INHIBITORS OF CHOLESTEROL SYNTHESIS | WARNER-LAMBERT COMPANY (US) | 1991-10-02 | — | — | EP | claimed |
| EP-0330172-A2 | Improved process for trans-6-[2-(substituted-pyrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis | WARNER-LAMBERT COMPANY (US) | 1989-08-30 | — | — | EP | claimed |
| WO-1989007598-A2 | IMPROVED PROCESS FOR TRANS-6-[2-(SUBSTITUTED-PYRROL-1-YL)ALKYL]PYRAN-2-ONE INHIBITORS OF CHOLESTEROL SYNTHESIS | WARNER-LAMBERT COMPANY (US) | 1989-08-24 | — | — | WO | claimed |
| US-4849531-A | Process for the preparation of 2,3-epoxyamides | BAYER AKTIENGESELLSCHAFT (DE) | 1989-07-18 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11414400-B2 | Method for preparing sulfonamides drugs | BCL2, BCL3, BAK1 | TKT 4092/4885HSP90AA1 2035/4885 |
| US-20210221788-A1 | METHOD FOR PREPARING SULFONAMIDES DRUGS | BCL2, BCL3, BAK1 | TKT 4092/4885HSP90AA1 2035/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.